The<unk>  prevention of<unk>  syndrome (APS) includes reduction of reversible risk factors such as smoking, hypertension, hyperlipidemia and life-long anticoagulation maintaining a target INR of 3.0-4.0
Antiphospholipid syndrome secondary prevention
Antiphospholipid syndrome primary prevention
Antiphospholipid syndrome medical therapy
Thrombophilia secondary prevention
Glanzmann's thrombasthenia medical therapy
Thrombophilia primary prevention
Von Willebrand disease medical therapy
Heparin-induced thrombocytopenia primary prevention